| ACT4U study (48 weeks) | PMS for 28 weeks (as a reference) | |
|---|---|---|
| # (Female) | 49 (93.9%) | 3881 (81.6%) |
| Age (>70 y.o.) | 57.9±2.1 (26.5%) | 58.8±12.9 (20.5%) |
| Concomitant respiratory disease | 22.4% | 17% |
| Oral corticosteroid (%)/MTX (%) | 59.2%/64.0% | 77.1%/54.2% |
| Infection (%)/OFSI (%) | 8 (16.8%)/1 (2.0%) | 389 (10.0%)/139 (3.6%) |